The premier 340B-specific gathering. Manufacturer dispute strategy, contract pharmacy compliance, federal litigation updates (4th Circuit ruling), HRSA audit prep.
Why It Matters
With Lilly/Novo claims-data mandates active and 4th Circuit ruling in favor of providers, 340B is in active flux. Critical for FQHC pharmacy directors.
Planning Context
Est. Attendance
700
FQHC Audience
75%
Preparation Checklist
Verify date, format, cost, and requirements at the official source.
Save the event to your calendar if it affects work, training, or hiring plans.
Check speaker or continuing-education deadlines before booking travel.
Follow the topic in Your Pulse to catch related signals.